Sarjapur Entity Allots CCPS Through Private Placement to Raise Capital
Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, known as Sarjapur Entity, has allotted Compulsoribly Convertible Preference Shares (CCPS) through a private placement aimed at raising additional capital. The allotment was conducted by the Board of Directors during a meeting held on June 23, 2026.The company issued two series of CCPS to identified investors. Sarjapur Entity allotted 12,00,000 fully paid-up Series A CCPS, with a face value of Rs. 50/- each. Additionally, 34,30,000 partly paid-up Series B CCPS were issued, carrying a face value of Rs. 50/- and a paid up amount of INR 5/-.
Both the Series A and Series B CCPS currently carry a conversion ratio such that each preference share can convert into a maximum of up to 5 equity shares of Sarjapur Entity.
The company confirmed plans for future capital infusion, stating that Sarjapur Entity is actively seeking further investments and finalizing other investors who may receive additional CCPS in due course.
Regarding the stability of ownership, Aster DM Healthcare Limited affirmed that its shareholding in Sarjapur Entity will remain at least 75% of the share capital, even after the conversion of the allotted Series A CCPS, Series B CCPS, and any Additional Investment received.
ASTERDM Stock Price Movement
Aster DM Healthcare Limited shares today slipped by 2.64% to settle at ₹765.85, closing lower following a volatile trading session. The stock traded within an intraday range of ₹759.50 to ₹799.00, with 930,320 shares recorded in the final trade.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.